We are live on ! Find out more
AZN icon

AstraZeneca
AZN

449 hedge funds and large institutions have $10.8B invested in AstraZeneca in 2016 Q3 according to their latest regulatory filings, with 82 funds opening new positions, 154 increasing their positions, 120 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

308% more call options, than puts

Call options by funds: $138M | Put options by funds: $33.7M

228% more first-time investments, than exits

New positions opened: 82 | Existing positions closed: 25

75% more funds holding in top 10

Funds holding in top 10: 4 → 7 (+3)

28% more repeat investments, than reductions

Existing positions increased: 154 | Existing positions reduced: 120

24% more capital invested

Capital invested by funds: $8.72B → $10.8B (+$2.1B)

13% more funds holding

Funds holding: 397 → 449 (+52)

1.66% more ownership

Funds ownership: 11.43% → 13.09% (+1.7%)

Holders
449
Holders Change
+52
Holders Change %
+13.1%
% of All Funds
11.98%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.19%
New
82
Increased
154
Reduced
120
Closed
25
Calls
$138M
Puts
$33.7M
Net Calls
+$104M
Net Calls Change
+$35.1M

Top Buyers

1
Dodge & Cox
Dodge & Cox
California
+$316M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$180M
3
ClearBridge Investments
ClearBridge Investments
New York
+$171M
4
Bank of America
Bank of America
North Carolina
+$146M
5
Viking Global Investors
Viking Global Investors
Connecticut
+$136M

Top Sellers

1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$212M
2
CI
Cambiar Investors
Colorado
-$93.2M
3
JP Morgan Chase
JP Morgan Chase
New York
-$42.5M
4
VOYA Investment Management
VOYA Investment Management
Georgia
-$31.8M
5
HI
Honeywell International
North Carolina
-$25.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
UCFA
301
United Capital Financial Advisors
Texas
$269K +$267K +4,088 New
WCM
302
Weatherstone Capital Management
Colorado
$264K – – –
BRWA
303
B. Riley Wealth Advisors
Florida
$264K +$21.6K +330 +9%
AAM
304
AR Asset Management
California
$263K – – –
VFA
305
Voya Financial Advisors
Connecticut
$260K +$257K +3,935 New
KAM
306
Kazazian Asset Management
Florida
$252K – – –
FIM
307
Fruth Investment Management
Texas
$251K – – –
TNBTD
308
Trustmark National Bank Trust Department
Mississippi
$251K +$250K +3,819 New
MMG
309
Monetary Management Group
Missouri
$248K – – –
FFBTD
310
First Financial Bank - Trust Division
Ohio
$246K -$10.5K -160 -4%
BIAS
311
Beacon Investment Advisory Services
New Jersey
$245K +$10.7K +163 +5%
HI
312
Hudock Inc
Pennsylvania
$240K -$26.7K -408 -10%
LAM
313
Lebenthal Asset Management
New York
$237K +$190K +2,913 New
FHA
314
First Horizon Advisors
Tennessee
$234K +$6.47K +99 +3%
MWM
315
Mission Wealth Management
California
$230K -$5.56K -85 -2%
BT
316
Beacon Trust
New Jersey
$230K – – –
B
317
BancorpSouth
Mississippi
$229K +$227K +3,478 New
WA
318
WealthTrust Axiom
Pennsylvania
$226K -$8.17K -125 -4%
DWT
319
Dorsey & Whitney Trust
South Dakota
$223K +$221K +3,374 New
CP
320
Camelot Portfolios
Ohio
$220K -$49K -750 -18%
AT
321
Argent Trust
Texas
$219K +$218K +3,337 New
CAM
322
Columbia Asset Management
Michigan
$218K +$217K +3,323 New
V
323
Veritable
Delaware
$217K -$110K -1,684 -34%
HKIM
324
Hayek Kallen Investment Management
Alabama
$217K +$216K +3,300 New
WS
325
Wedbush Securities
California
$215K +$214K +3,277 New
11 12
13
14 15

AZN Hedge Fund Activity: Q3 2016 in Review

449 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q3 2016, worth a combined $10.8B — up 24% from $8.72B a quarter earlier.

Buyers outnumbered sellers: 82 funds opened new AZN positions and 25 closed out — a net gain of 57 holders — while 154 added to existing stakes and 120 trimmed.

The largest buyer was Dodge & Cox, adding an estimated $316M. The largest seller was Arrowstreet Capital, cutting an estimated $212M.

  • 449 institutional investors held AstraZeneca (AZN) as of Q3 2016, up from 397 in Q2 2016.
  • Funds reported $10.8B of AstraZeneca stock for Q3 2016, up 24% quarter-over-quarter.
  • 82 funds opened new AstraZeneca positions in Q3 2016 and 25 closed out, a net change of +57 holders.
  • The largest AstraZeneca buyer in Q3 2016 was Dodge & Cox, an estimated $316M added.
  • The largest AstraZeneca seller in Q3 2016 was Arrowstreet Capital, an estimated $212M sold.

Based on aggregated 13F filings for Q3 2016.